30 May 2017 | 1:40 PM
 

Dishman Pharmaceuticals & Chemicals Ltd. Share Price Live (BSE)
0

BSE Code: 532526 | NSE Symbol: DISHMAN
301.05
8.40
(2.88 %)
29 May 2017 | 03:45 PM
Change company
  • Open (Rs)
    293.00
  • Prev. close (Rs.)
    292.65
  • High (Rs.)
    304.30
  • Low (Rs.)
    278.11
  • 52W H (Rs.)
    346.25
  • 52W L (Rs.)
    127.60
  • Volume (Rs.)
    460499
  • MCap (Rs in Cr.)
    4,858.77
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
14.85
Operating Margin (%)
19.91
Gross Profit Margin (%)
10.34
Net Profit Margin (%)
7.60
Total Debt/Equity
0.60
Dividend payout Ratio (Net Profit)
16.21
Earning Retention Ratio
83.79

News

29 Mar 2017 - 11:52:00-Shares of Dishman Pharmaceuticals rallied over 15 per cent on the Bombay Stock Exchange after the dr...
28 Mar 2017 - 12:04:00-Shares of Dishman Pharmaceuticals rallied 20 per cent and locked in upper circuit on the Bombay Stoc...
08 Mar 2017 - 12:34:00-Drug firm Dishman Pharmaceuticals and Chemicals Ltd today said there was fire at one of the units of...
02 Mar 2017 - 09:27:00-Dishman Pharmaceuticals has said that it has made full payment of Principal Repayment/Redemption alo...

Announcements

22-May-2017
Dishman Pharmaceuticals & Chemicals Ltd. - Suspension of Trading
19-May-2017
Dishman Pharmaceutic - Fixes Record Date For The Purpose Of Allotment Of Equity Shares Under Scheme Of Arrangement & Amalgama
17-May-2017
Dishman Pharmaceutic - Updates
16-May-2017
Dishman Pharmaceutic - Financial Result For 31St March 2017
16-May-2017
Dishman Pharmaceutic - INTIMATION OF MEETING OF MANAGEMENT COMMITTEE OF BOARD OF DIRECTORS ON 05 19 2017 TO FIX RECORD DATE

Religare Research

29 May 2017 | 06:40 PM
Gold futures ended the week in positive, despite a rise in investor expectations that Federal Reserv...
29 May 2017 | 05:44 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
29 May 2017 | 03:06 PM
Century Plyboards (I) Ltd.’s Q4FY17 result was inline with our estimates. The company reported 9% yo...
29 May 2017 | 02:25 PM
Swaraj Engines Ltd (SEL) reported healthy set of numbers for Q4FY17 with 41% YoY growth in net reven...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
11,92,300 26.47 103.92 -0.34
11,92,300 26.47 642.60 -0.34
11,92,300 26.47 666.99 -0.33
11,92,300 26.47 128.93 -0.33
0 19.95 50.48 -1.37

Shareholding Pattern

       
Promotors61.40%
Mutual Funds/UTI9.57%
FI/Banks0.70%
Insurance0.70%
FII10.57%
Government0.00%
Others5.11%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,073.65(1.61)
3280
 Sanofi India Ltd.
4,019.95(0.34)
3325
 Pfizer Ltd.
1,650.00(-0.23)
3370
 Strides Shasun Ltd.
912.55(3.85)
13158

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Dishman Pharmaceuticals & Chemicals Ltd.-7.5570.3561.95
NIFTY(S&P CNX)302.85737.051,474.50
BSE SENSEX1,254.612,432.474,781.78
BSE 500140.10969.812,070.65

Corporate Details

Key Personal
Arpit J Vyas
Managing Director & CFO
Deohooti J Vyas
Whole Time Director
Janmejay R Vyas
Chairman & Managing Director
Key Address
Registered Office
Bhadr - Raj Chambers Swastik Cross Road Navrangpura,Ahmedabad,Gujarat

Tel:079-26443053 26445807, Fax:079-26420198

dishman@dishmangroup.com
http://www.dishmangroup.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Dishman Pharmaceuticals & Chemicals Ltd. that will help you decide whether to buy, sell or hold Dishman Pharmaceuticals & Chemicals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Dishman Pharmaceuticals & Chemicals Ltd.